Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > We Sit and Wait
View:
Post by gonefishing2022 on Jan 21, 2025 12:01pm

We Sit and Wait

Nothing is going to Change until we get NEWS!!! 
What are we waiting for NEWS

They are doing another PP they said they hoped to do it a higher rate,they said maybe we get a partner and Nothing 

They said BTD in fall and now spring and possibly AA instead 

They need to act and stop the pipe dream and save lives. 

Now they are doing another PP again and will raise less than 1 Million and do it again in 2.5 months if they don't have news 

They need positive news and get it happing .GET IT DONE  

NEWS NOT MISSED DEADLINES
Comment by McBullish on Jan 21, 2025 12:18pm
I dont know where you're getting your information but thats not my take on it. BTD moves the needle for SP, AA moves the needle for treatment and revenue streams  BTD has a 1 in 5 approval rate.  BTD is on track for Q1 submittal. The data being collected from the remaining candidates reinforces our long term CR numbers, which is the differentiator between the other competeting ...more  
Comment by gonefishing2022 on Jan 21, 2025 1:22pm
I believe they have a fantastic Treatment and cure but they have not even submitted BTD and this is end of January, so add atleast 60 days on top of this and end of March at best but you can't disagree with me on the PP they are going to raise atleast 2 more times before we get good news. 
Comment by McBullish on Jan 21, 2025 1:42pm
It possible that we submit BTD by the end of January, if not the first week in Feb.  The PP should carry us through ~3 months. Its possible to get FDA response by end of March or early April. It will be close. You may be correct, it might require another PP. We need the long term trial data from the patients that were not originally included due to availability to give us our best shot at ...more  
Comment by CAinPlap on Jan 21, 2025 1:52pm
Matthew indicated BTD submission will not be in January but very likley by end of Feb.
Comment by rollthedice10 on Jan 21, 2025 2:08pm
So what? I'll wait. This doesn't mean TLT has stopped working on other things by any means. Seems to be so much focus on BTD when there are other fish frying. Buckle up. JMHO
Comment by Oilminerdeluxe on Jan 21, 2025 2:29pm
End of February seems like a good possibility, if I read the tea leaves correctly.  No later than during Q1 seems to be the timeline right now. So Feb or March. As long as it gets done. If Dr. Lbiati has worked her magic, an official BTD approval should open doors after that. In a normal world at least. Perhaps the newsletter writers will be a bit more interested too.  Does anyone have ...more  
Comment by Maxcitrac on Jan 21, 2025 1:36pm
McBullish thanks, in your post the approval ratio is not quite right. In this article. Breakthrough Therapy Cancer Drugs and Indications With FDA Approval: Development Time, Innovation, Trials, Clinical Benefit, Epidemiology, and Price in: Journal of the National Comprehensive Cancer Network Volume 22 Issue 4 (2024) It is written '' 39% of BTD request were approved. Not bad, and much ...more  
Comment by McBullish on Jan 21, 2025 1:44pm
Thanks for the correction! Definitely improves our chances.
Comment by bmk211 on Jan 21, 2025 1:54pm
Its a no brainer and getting approved.  There isn't a single reason not to approve this outside of consipiracy theories.   This is going to be approved and that is all there is to it.  I only wish I had more money and knew of this sooner.  its 100% safe and kills cancer.   APPROVED. 
Comment by bmk211 on Jan 21, 2025 2:01pm
There is no way to properly value or asses a company like Theralase.  Its too explosive.   Potentially worth $4 a share but maybe $150 if all the stars align.   I only imagine big pharma puzzled on how to even go about dealing with them this early in the game.  Its just too early.  How could anyone possibly even arrive on a proper valuation?  How do you get ...more  
Comment by Legit62 on Jan 21, 2025 4:58pm
Im up for .50 US now. will be happy with that
Comment by Pandora on Jan 21, 2025 6:18pm
Did anyone tune into the Trump presentation this afternoon after the market close. He had a meeting with a few big money investors and they are concentrating on a build up of big data centers starting in Texas and that will kick off large research through AI. Larry Ellison of Oracle fame was one of the guys that spoke and he related how AI would be used in a Cancer vaccine project. He said they ...more  
Comment by O12009 on Jan 21, 2025 7:21pm
At one time Theralase was talking they were doing preclinical testing on A cancer vaccine. With the activation properties of Metaform Pfizer or GSK could be very interested in acquiring the rights to develop a cancer vaccine using our drug. Very interesting.
Comment by BlueFranky on Jan 21, 2025 7:29pm
Indeed, preclinical testing of a cancer vaccine  Oh wait, let's not forget this, from the company website:  "we found that nanomolar and micromolar concentrations of RuvidarTM were all that was required in order to inactivate 90 to 99.9% of all seven viruses that we tested, INCLUDING H1N1 influenza virus, coronavirus, Zika virus, poxvirus and herpes virus. In fact, RuvidarTM ...more  
Comment by StevenBirch on Jan 21, 2025 8:19pm
Looks like you were right 012009, when you said 3 more weeks to get the full data on 63, with CAinPlap reporting BTD likely submitted by the end of Feb. So hopefully we could be looking at Mar/early Apr?
Comment by menoalittle on Jan 22, 2025 9:56am
If Cancer is near the front of the line in AI research, why hasn't AI still hasn't been able to figure out the primary cause of it?   Oh... so you don't believe me? Try asking any AI engine if cancer is a genetic disease.  Then ask if cancer is a metabolic disease.  Then ask whether is it a genetic or a metabolic disease.  Then let us know here whether or ...more  
Comment by bmk211 on Jan 22, 2025 11:50am
70 billion dollars
Comment by DeathXray33 on Jan 22, 2025 12:33pm
Lot's of problems with mRNA... --------------------------------------------------------------- "As a primary MOA, Rutherrin, has been demonstrated clinically to destroy NMIBC, when activated by light, and preclinically to destroy GBM and Non-Small Cell Lung Cancer ("NSCLC"), when activated by x-ray radiation."
Comment by Pandora on Jan 22, 2025 11:35pm
An outfit called Onco-Innovations was mentioned the other day as a relatively new entry into the cancer fighting market. I see a news item today saying they have just signed a letter of intent with a Canadian company, Inka Health, which has an AI driven platform which accelerates precision oncology breakthroughs. https://stockhouse.com/news/press-releases/2025/01/22/onco-innovations-enters-into ...more